Schlesinger Group UK is Open for Essential In-Person Research

We are delighted to share good news today that Schlesinger Group UK is open for essential face-to-face research, including healthcare research and studies focused on COVID-19.

Our team is following MRS guidance which interprets the latest COVID-19 government restrictions, imposed in November 2020, and the implications for face-to-face data collection in England. MRS states, “research practitioners must only undertake essential face-to-face data collection which cannot be achieved using other methods.”

Supporting Your Research Objective

As responsible researchers, our UK team will conduct a risk assessment of your proposed in-person study and determine whether it is essential research. Where in-person is not an option, our proprietary online platforms powered by 20|20 Research support easy-to-use online methods to allow you to continue your important research.

Setting the Benchmark for Safe Research

From the outset, Schlesinger Group has led the way in developing a plan for responsible in-person research. Our COVID-19 Taskforce continues to review protocols and performance for exceptional outcomes.

View MRS Guidelines | View Our Facility Precautions | Request a Consultation

Let’s Talk About Your Upcoming Study

Hanna Assouline
Managing Director, Schlesinger Group UK
Hanna.Assouline@SchlesingerGroup.com